Directory → Organotropona funds → The governing bodies of the urinary and reproduction → Dioretiki → Brinerdin
This page is translated automatically with a help of Google Translate

Brinerdin

See also Dihydralazine

Roman name

Brinerdin

Storage conditions

List B. In a dry, the dark spot.

The registration

007,310 (Ann.2001)

Of drugs

Drugs from the properties of its constituent components.

Indications for use

Applied in hypertensive disease (stable elevated arterial pressure), and symptomatic gipertoniah.

Dosing and Administration

Is inwards to 1 tablet 1 to 3 times a day (depending on the nature of his illness and the patient). The course of treatment is from 10 days to several months.

Side-Effects

Nausea, vomiting, gipokaliemia (reduction in the level of potassium in the blood), ortostatical hypotension (fall in blood pressure in the transition from the horizontal to the vertical), muscle weakness.

Contraindications

Same as for of its components.

Form of

Tablets containing rezerpina - 0.0001 g (0.1 mg), digidroergochristina - 0.0005 g (0.5 mg), brinaldiksa -0.005 g (5 mg) in the package of 30 pieces.

All products of this group